58,903 results on '"Department of Obstetrics and Gynaecology"'
Search Results
2. Hysteroscopy With Fundus Uterus Scratching Incision VS Office Hysteroscopy Before ET With Donor Eggs
- Author
-
3rd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki and Papanikolaou Evaggelos, Prof Dr Papanikolaou G. Evangelos
- Published
- 2020
3. Mechanical Dilation of the Cervix in a Scarred Uterus (MEDICS)
- Author
-
Department of Obstetrics and Gynaecology, National University Hospital, Yong Loo Lin School of Medicine, National University Hospital, Singapore, National University of Singapore, and Soe-na Choo, Medical Officer
- Published
- 2019
4. Impact of Deep Endometriosis Surgery on Bladder Function
- Author
-
Department of Obstetrics and Gynaecology, Insubria Unievrsity, Varese (Italy) and Laterza Rosa Maria, Dr. med
- Published
- 2014
5. Role of lymphadenectomy in ovarian cancer
- Author
-
Benedetti Panici, Pierluigi and Angioli, Roberto
- Published
- 2002
- Full Text
- View/download PDF
6. Are we missing the issues that really matter? A mixed method study on the prevalence, severity and experience of genitourinary symptoms and the impact on sexual function and QoL in postmenopausal women on endocrine therapy for early breast cancer
- Author
-
Friedlander, Michael, Clinical School - Prince of Wales Hospital, Faculty of Medicine, UNSW, Hickey, Martha, Department of Obstetrics and Gynaecology, University of Melbourne and The Royal Women's Hospital, Victoria, Australia, Peate, Michelle, Department of Obstetrics and Gynaecology, University of Melbourne and The Royal Women's Hospital, Victoria, Australia, De Souza E Sousa, Mariana, Clinical School - Prince of Wales Hospital, Faculty of Medicine, UNSW, Friedlander, Michael, Clinical School - Prince of Wales Hospital, Faculty of Medicine, UNSW, Hickey, Martha, Department of Obstetrics and Gynaecology, University of Melbourne and The Royal Women's Hospital, Victoria, Australia, Peate, Michelle, Department of Obstetrics and Gynaecology, University of Melbourne and The Royal Women's Hospital, Victoria, Australia, and De Souza E Sousa, Mariana, Clinical School - Prince of Wales Hospital, Faculty of Medicine, UNSW
- Abstract
The underlying hypothesis of this PhD is that the negative impact of adjuvant endocrine therapy on genitourinary symptoms in postmenopausal women with early breast cancer has been underestimated in clinical trials and that there are a myriad of genitourinary symptoms related to or exacerbated by endocrine therapies that are commonly not reported by women to their oncologists. These symptoms can be troublesome and may lead to noncompliance with treatment, especially if associated with other side effects. This issue has not been comprehensively addressed, resulting in uncertainty regarding the frequency and severity of genitourinary adverse effects associated with antiestrogens and their potential impact on quality of life (QoL). Furthermore, no studies have comprehensively and prospectively evaluated the full range of genitourinary symptoms from before therapy begins and over time. These symptoms include urinary frequency, urgency, incontinence, dysuria, prolapse among others. This study fills an important gap in the current literature and is clinically important as interventions could be used to better manage and treat many of these symptoms.A number of data collection methods and instruments were used in this project, selected on their ability to address the proposed research questions. Using a qualitative approach, with semi-structured interviews, Study I sought an in-depth insight of the genitourinary symptoms experienced by women with early breast cancer on antiestrogen therapy and an understanding on how symptoms impact on daily life and sexual function. Study II employed a prospective design, using carefully selected validated instruments, to measure the prevalence and severity of genitourinary symptoms in postmenopausal women with breast cancer (prior to adjuvant endocrine therapy) and documented the trajectory of symptoms over time. The impact of genitourinary symptoms on sexual function and QoL was also investigated. The study attempted to identify predicto
- Published
- 2015
7. Monoclonal antibodies to human sperm antigens -- II
- Author
-
Department of Obstetrics and Gynaecology, University of Michigan, Ann Arbor, MI 48109, U.S.A., Department of Obstetrics and Gynaecology, The University of British Columbia, Vancouver, Canada, Lee, Chi-Yu Gregory, Wong, Eric, Richter, Diane E., Menge, Alan C., Department of Obstetrics and Gynaecology, University of Michigan, Ann Arbor, MI 48109, U.S.A., Department of Obstetrics and Gynaecology, The University of British Columbia, Vancouver, Canada, Lee, Chi-Yu Gregory, Wong, Eric, Richter, Diane E., and Menge, Alan C.
- Abstract
As part of our continuous effort to elucidate the biochemical and immunological nature of human sperm surface antigens, monoclonal antibodies to human spermatozoa were generated by improved hybridoma techniques. Following immunizations with the membrane fraction of human spermatozoa and cell fusions, hybrid cells were cultured in a semi-solid HAT-selection medium to maximize the number of monoclones recovered. Subcultures were made in liquid phase 7 to 10 days after cell fusions by removing colonies from the initial medium. Based on the results of screening by microplate enzyme-linked immunoassay, 143 of 552 initial clones were found to secrete antibodies to human sperm antigens. More than one-hundred independently derived hybrid cell lines were established. Using indirect immunofluorescent procedures, 62 cell lines were shown to produce antibodies to surface antigens of human spermatozoa. Unique sperm antigens that react with monoclonal antibodies were identified by the SDS gel/protein blot radioimmunobinding method. Sperm agglutinating and immobilizing antibodies were exhibited by 4 and 15 hybrid cell lines, respectively. Fourteen of the monoclonal antibodies also exhibited cross-reactivity with methanol-fixed sperm cells of the rabbit or mouse or both whereas a reaction was not seen with viable sperm of these species. Generation of monoclonal antibodies against a wide spectrum of human sperm antigens should facilitate future investigations regarding immunologic-associated human infertility and fertility control.
- Published
- 2006
8. Current trends in caesarean section in University of Calabar Teaching Hospital Calabar-Nigeria
- Author
-
Iklaki, CU; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, Calabar, Ekabua, JE; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, Calabar, Agan, TU; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, Calabar, Ekanem, EI; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, Calabar, Asuquo, EEJ; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, Calabar, Iklaki, CU; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, Calabar, Ekabua, JE; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, Calabar, Agan, TU; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, Calabar, Ekanem, EI; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, Calabar, and Asuquo, EEJ; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, Calabar
- Abstract
The rising caesarean section rate is becoming a cause for concern among many obstetricians all over the world more so in developing countries where there is strong aversion to caesarean section. A five year study was conducted between 1998 to 2002 to evaluate incidence of caesarean section in the University of Calabar Teaching Hospital and factors that influence the rising trend in caesarean section rate in our environment and also to find out the case fatality rate associated with this surgical operation. Caesarean section accounted for 19.8% of the total deliveries while spontaneous vaginal delivery accounted for 75.6%. Other modes of deliveries included assisted breech delivery (2.8%), vacuum (1.5%), forceps – (0.5%), destructive operations (0.14%). The caesarean section rate increased progressively from 17.9% in 1998 to 21.9% in 2002. Emergency caesarean sections (80.0%) were more frequently performed than elective cases (20.0%). Majority of the patients (82.9%) were booked while only 17.1% were unbooked. The commonest indication for emergency caesarean section was obstructed labour due to cephalopelvic disproportion (25%), followed closely by fetal distress (13.9%). The case fatality from caesarean section was calculated as 1.29%. It is obvious that there is increase in the caesarean section rate in our environment, which is in line with what is happening in the developed countries where the operation is more liberally used. In consonance with finding in other Teaching Hospitals, caesarean section appears to be on the increase in Nigeria. Although it has been suggested that increased rates of caesarean section would reduce the unusually high perinatal mortality in this area, this has not been subjected to objective scientific analysis. Keywords: caesarean section, cephalopelvic disproportion, obstructed labour Mary Slessor Journal of Medicine Vol. 5(1), 2005: 41-45
- Published
- 2005
9. A Seven Year Clinical Review of Macrosomic Births in Calabar
- Author
-
Ekabua, JE; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, P M B 1278, Calabar, Nigeria., Ukombe, EB; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, P M B 1278, Calabar, Nigeria., Agan, TU; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, P M B 1278, Calabar, Nigeria., Iklaki, CU; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, P M B 1278, Calabar, Nigeria., Etuk, SJ; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, P M B 1278, Calabar, Nigeria., Itam, IH; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, P M B 1278, Calabar, Nigeria., Ekabua, JE; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, P M B 1278, Calabar, Nigeria., Ukombe, EB; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, P M B 1278, Calabar, Nigeria., Agan, TU; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, P M B 1278, Calabar, Nigeria., Iklaki, CU; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, P M B 1278, Calabar, Nigeria., Etuk, SJ; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, P M B 1278, Calabar, Nigeria., and Itam, IH; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, P M B 1278, Calabar, Nigeria.
- Abstract
Pregnancies associated with fetal macrosomia in the University of Calabar Teaching Hospital, Calabar, over a seven years period were studied. The aims were to establish the incidence of fetal macrosomia and possible risk factors associated with macrosomic births. The incidence of macrosomic births was 4.0% or 1 in 25 deliveries. Mean maternal age was 27.2 years. About 58% of women were para 5 and above. Sex ratio of babies showed a male predominance of 2.1 to 1. History of previous macrosomic birth was obtained in 28.0% of cases. Maternal weight greater than 90kg was observed in 31.4%, gestational diabetes in 2.6% and post-term pregnancies in 9.6% of cases. Main disorder of labour were obstructed labour (14.4%) and prolonged second stage of labour (5.2%). The use of instrumental vaginal delivery was significantly higher in macrosomic than in non-macrosomic births (x2 = 14.34 p=0.0001). However the use of abdominal delivery in macrosomic birth was not significantly higher than in non-macrosomic births (x2=0.22 p=0.6415). Fetal macrosomia is a cause of peri-natal morbidity and mortality in Calabar. There is a call for a high index of suspicion whatever the identified risk factors are present. Key Words: Fetal macrosomia, incidence, and associated risks. Mary Slessor Journal of Medicine Vol.4(1) 2004: 32-36
- Published
- 2005
10. Primary caesarean section in nulliparous and grandmultiparous Saudi women from the Abha region: Indications and outcomes
- Author
-
Sobande, AA; Department of Obstetrics and Gynaecology, College of Medicine and Medical Sciences, King Khalid University, P.O. Box 641, Abha, Saudi Arabia, Archibong, EI; Abha Maternity Hospital, Abha, Saudi Arabia., Eskandar, M; Department of Obstetrics and Gynaecology, College of Medicine and Medical Sciences, King Khalid University, P.O. Box 641, Abha, Saudi Arabia, Sobande, AA; Department of Obstetrics and Gynaecology, College of Medicine and Medical Sciences, King Khalid University, P.O. Box 641, Abha, Saudi Arabia, Archibong, EI; Abha Maternity Hospital, Abha, Saudi Arabia., and Eskandar, M; Department of Obstetrics and Gynaecology, College of Medicine and Medical Sciences, King Khalid University, P.O. Box 641, Abha, Saudi Arabia
- Abstract
Objective: To assess the indications for and outcomes of primary caesarean section (PCS) perfomed in nulliparous and grandmultiparous women in the Abha region of Saudi Arabia. Methods: A retrospective cohort study. Materials: 393 nulliparous women (para 0) (NPG) and 432 grandmultiparous women (parity>5) (GMPG) who had PCS at the Abha Maternity Hospital (AMH) over a 3-year period, (1997-1999) formed the basis of the study. Results: The PCS rates in NPG and GMPG were 19.4% and 18.3% respectively with no statistically significant difference. (p>0.05). There were statistically significant differences between the two groups regarding the mean age, blood loss during surgery, post operative haemoglobin, and birth weight were compared, p 0.05. The most common indication for surgery in the two groups of patients was fetal distress (NPG =28%, GMPG = 25%: p=NS), followed by failure of progress in labour. (NPG = 22.7%, GMPG = 21.6%, p = NS). Antepartum haemorrhage (APH) was the indication for PCS in 6.8% of the NPG and 13.9% of the GMPG, (p <0.05). Multivariate linear regression analysis indicated that maternal age and booking status significantly affected birth weight (p=0.004,p=0.022 respectively). However, neither birth weight nor low Apgar score was affected by the indications for CS or parity. While there were no perinatal deaths in the series, no statistically significant difference was found between the two groups with regards to low Apgar score (0.05. Conclusion: The major indications for PCS were the same in the NPG and GMPG in our study while the CS rates were similar in both groups. However, APH and its inherent complications occured more commonly in the GMPG. Neonatal morbidity was similar in both groups of women, but the mean birth weight was significantly higher in the GMPG. However, in order to reduce the high CS rate in these groups of patients, and in our obstetric population in general, it is suggested that CTG be used appropriately in high risk women and tha
- Published
- 2004
11. Obstetric Practices in Spiritual Churches in South Eastern Nigeria
- Author
-
Udoma, EJ; Department of Obstetrics and Gynaecology, University of Calabar, John, ME; Department of Nursing Science, College of Medical Sciences, University of Calabar, Udosen, GE; Department of Nursing Science, College of Medical Sciences, University of Calabar, Udo, AE; Department of Obstetrics and Gynaecology, University of Calabar, Udoma, EJ; Department of Obstetrics and Gynaecology, University of Calabar, John, ME; Department of Nursing Science, College of Medical Sciences, University of Calabar, Udosen, GE; Department of Nursing Science, College of Medical Sciences, University of Calabar, and Udo, AE; Department of Obstetrics and Gynaecology, University of Calabar
- Abstract
Spiritual-church based health clinics identified by public health coordinators were visited, between May 2002 and September 2002. Practitioners were interviewed regarding their obstetric practices and facilities available to them. The 47 spiritual church based birth places were located in urban and sub-urban area, with majority of labour rooms attached to the churches. Fifteen (36.9%) of each birthing places had concrete floor, running (tap) water and electricity. Thirty-three (70.2%) had vono beds while 15(31.9%) had babies' cots, and orthodox delivery instruments in 10 (21.3%). For conducting delivery, 33 (70.2%) used delivery couch or wooden tables, 9(11.1%) had native earthen bed while 5(10.6%) conducted delivery on mats spread on the floor. The attendants were women aged between 25 and 65 years with 20 (20.6%) married to Pastors in charge of the church, and 54 (55.7%) had no formal education. Twenty-one (44.7%) of the centers kept delivery records with no records of deaths or complicated cases. Twenty-eight (59.6%) centers performed vaginal examination during pregnancy and out of these 17 (60.7%) used their bare hands lubricated with olive oil. All attendants prescribed prayers and fasting at least monthly to pregnant women with administration of “holy water” and olive oil. Their predictions of complicated cases were based on God's revelation in 21 (44.7%). During delivery, attendants in 14 (29.8%) centers used gloves while 33 (70.2%) used bare hands with or without olive oil. Regarding what each center does when confronted with complications, majority 26 (55.3%) offer prayers and invite prayer band, while 14 (29.8%) refer patients to orthodox health facilities. Suggestions are made on how to improve their quality of obstetric care with the aim of reducing maternal mortality in our environment. Mary Slessor Journal of Medicine Vol.3(2) 2003: 51-56
- Published
- 2004
12. A Prospective Comparative Study of the Bacterial Flora of the Vagina and Cervix in Non-Pregnant Women of Childbearing Age in Calabar, Nigeria.
- Author
-
Archibong, EI; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, Calabar, Nigeria, Itam, IH; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, Calabar, Nigeria, Opara, AA; Formerly of Department of Biological Sciences, University of Calabar, Calabar, Nigeria, Ikefun, CA; Formerly of Department of Biological Sciences, University of Calabar, Calabar, Nigeria, Archibong, EI; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, Calabar, Nigeria, Itam, IH; Department of Obstetrics and Gynaecology, University of Calabar Teaching Hospital, Calabar, Nigeria, Opara, AA; Formerly of Department of Biological Sciences, University of Calabar, Calabar, Nigeria, and Ikefun, CA; Formerly of Department of Biological Sciences, University of Calabar, Calabar, Nigeria
- Abstract
A qualitative comparative study of the bacterial flora of the vagina and cervix of 90 non-pregnant women of childbearing age (18-35 years) in Calabar was undertaken. The study revealed that both aerobic and microaerophilic organisms as well as the strictly anaerobic bacteria constituted the microflora of the lower genital of this group of women. Of the 90 women sampled, Lactobacilli were the most frequently isolated organism in both the cervix and vagina, occurring in 62.2% and 75.6% and the samples respectively. Proteus species were the least in incidence, occurring in only 4% of either the cervical or vaginal specimens. The following pathogenic organisms were isolated in both the vagina and cervix: Escherichia coli, Staphylococcus aureus, Candida albicans, Clostridium species and Beta-haemolytic Streptococci. In general, the same types of organisms were isolated in both the cervical and vaginal samples, although the incidence in the two sources varied. Mary Slessor Journal of Medicine Vol.3(2) 2003: 1-4
- Published
- 2004
13. Socio-Demographic Determinants of Eclampsia in Calabar; A Ten-Year Review
- Author
-
Itam, IH; Department of Obstetrics and Gynaecology, Maternity Annex, University of Calabar Teaching Hospital, Calabar, Ekabua, JE; Department of Obstetrics and Gynaecology, Maternity Annex, University of Calabar Teaching Hospital, Calabar, Itam, IH; Department of Obstetrics and Gynaecology, Maternity Annex, University of Calabar Teaching Hospital, Calabar, and Ekabua, JE; Department of Obstetrics and Gynaecology, Maternity Annex, University of Calabar Teaching Hospital, Calabar
- Abstract
A ten-year review of the socio-demographic determinants of eclampsia was conducted at the University of Calabar Teaching Hospital (UCTH) Calabar from January 1988 to December, 1997. There were 12.749 deliveries during the study period, with 38 documented cases of eclampsia, giving an incidence of 3.0 per 1000 births. The mean age of the eclamptics was 21.3 years and mean parity was 1.3 children. The incidence of twin gestation among exclamptics was 158 per 1000 births. Five (13.2%) patients had past histories of eclampsia, while in 7 (18.4%) cases history of change of spouse was obtained in the index pregnancy. Thirty three (86.8%) patients were unbooked for antenatal care and eclamptic fits occurred more often in the antenatal period (55.3%). Majority of patients (39.5%) had no formal education and 34.25% were subsistence farmers living in the suburbs of Calabar. More cases of eclampia presented in the rainy season (May to October) than in the dry season (November to April) – 63.2% versus 36.8%. Knowledge of the socio-demographic determinants of eclampsia can be used in planning measures to reduce the incidence of this preventable obstetric emergency. Mary Slessor Journal of Medicine Vol.3(2) 2003:72-74
- Published
- 2004
14. Risk-stratification of endometrial carcinoma: Prediction of an advanced disease and features of the primary tumor
- Author
-
Helsingin yliopisto, lääketieteellinen tiedekunta, kliininen laitos, Helsingfors universitet, medicinska fakulteten, institutionen för klinisk medicin, University of Helsinki, Faculty of Medicine, Institute of Clinical Medicine, Department of obstetrics and gynaecology, Luomaranta, Anna, Helsingin yliopisto, lääketieteellinen tiedekunta, kliininen laitos, Helsingfors universitet, medicinska fakulteten, institutionen för klinisk medicin, University of Helsinki, Faculty of Medicine, Institute of Clinical Medicine, Department of obstetrics and gynaecology, and Luomaranta, Anna
- Abstract
Risk-stratification is an essential step in planning of the treatment of patients with endometrial carcinoma, as it allows the omission of lymphadenectomy and/or adjuvant treatments in patients who are at low risk for extrauterine spread and have a good prognosis. This thesis consists of three cohort studies and one meta-analysis that were conducted to evaluate the reliability of methods that are currently available for the risk-stratification of endometrial carcinoma, and to develop new methods that might be clinically applicable. Cohort studies were based on a sample of 1166 women who were surgically treated for endometrial carcinoma at the Department of Obstetrics and Gynecology, Helsinki University Hospital, between January 2007 and December 2013. In the first study, previously recognized risk factors for an advanced stage and poor outcome were used to create a calculatory score to predict lymph node and distant metastasis in endometrial carcinoma. The score combining weighted risk factors was: (2 x leukocytosis) + (3 x thrombocytosis) + (7 x elevated CA125) + (4 x preoperative high-risk histology, defined as grade 3 endometrioid or nonendometrioid carcinoma). Depending on the number of risk factors of an individual patient, the score ranged from 0 to 16 points. Using six as the cut-point for positive and negative test results, the area under curve for this total score was 0.823, with 71.6% sensitivity, 75.2% specificity, 25.9% positive predictive value, and 95.7% negative predictive value. In the second study, the reliability of macroscopic pelvic lymph node findings at surgery in predicting para-aortic metastasis was evaluated. Lymph nodes were considered grossly positive based on size and morphology. In patients who underwent comprehensive lymphadenectomy (n = 117), grossly positive pelvic nodes predicted para-aortic metastasis with a sensitivity of 52.4% and specificity of 93.8%. The positive and negative likelihood ratios were 8.4 and 0.51, respectively. Th, Kohdunrunkosyöpä on länsimaissa yleisin gynekologinen syöpä, sen ilmaantuvuus on lisääntymässä. Suomessa uusia kohdunrunkosyöpätapauksia todetaan lähes 900 vuodessa. Kohtuun rajoittuneessa taudissa ennuste on hyvä, jopa 90% potilaista on elossa viiden vuoden kuluttua diagnoosista. Jos leviämistä todetaan, ennuste huononee selvästi. Tyypillinen ensioire on postmenopausaalinen tai nuoremmalla poikkeava verinen emätinvuoto. Tavallisesti diagnoosiin päästään kohdun sisälimakalvolta otetusta kudosnäytteestä. Vaginaalinen ultraäänitutkimus on osa perusselvittelyjä. Muita kuvantamistutkimuksia, kuten magneettikuvausta ja tietokonetomografiaa, käytetään todetun kasvaimen piirteiden tarkempaan selvittelyyn ja imusolmuke- ja muiden etäpesäkkeiden etsimiseen. Kasvaimen ominaispiirteiden perusteella voidaan kohdunrunkosyöpäpotilaalle ennen hoitojen aloittamista määritellä riskiluokka taudin leviämisen riskin suhteen. Kohdunrunkosyövän hoidon perusta on leikkaus, jonka laajuuden määrittää leikkausta edeltävän riskiluokituksen tulos. Matalassa riskiluokassa pelkkä kohdun, munasarjojen ja munajohtimien poisto on riittävä hoito. Kohtalaisen ja suuren riskin luokissa poistetaan kohdun ja sen sivuelinten lisäksi paikalliset imusolmukkeet lantiosta ja para-aortaalisesti (vatsa-aortan ympäriltä). Leikkauksen jälkeisten liitännäishoitojen (sädehoito ja/tai solunsalpaajahoito) käyttö päätetään usein sen perustella, löytyykö lopullisessa patologin tutkimuksessa imusolmukkeista etäpesäkkeitä vai ei. Nykyisin käytössä olevat riskiluokitusmenetelmät toimivat puutteellisesti. Riski tulee usein ali- tai yliarvioiduksi, mikä altistaa potilaan ali- tai ylihoidolle. Väitöskirjatutkimuksen tavoitteena oli kehittää uusia menetelmiä kohdunrunkosyövän imusolmuke-etäpesäkkeiden riskin arvioimiseen, ja arvioida olemassa olevien menetelmien toimivuutta. Aineistona oli 1/2007 ja 12/2013 välisenä aikana HYKS Naistentautien ja synnytysten yksikössä leikatut kohdunrunkosyöpäpotilaat. Sairauskertomuksista et
- Published
- 2015
15. Improving attendance to cervical cancer screening: Effects of HPV-testing on self-taken samples in the Finnish cervical cancer screening programme
- Author
-
Helsingin yliopisto, lääketieteellinen tiedekunta, kliininen laitos, Helsingfors universitet, medicinska fakulteten, institutionen för klinisk medicin, University of Helsinki, Faculty of Medicine, Institute of Clinical Medicine, Department of Obstetrics and Gynaecology, Mass Screening Registry, Finnish Cancer Registry, Virtanen, Anni, Helsingin yliopisto, lääketieteellinen tiedekunta, kliininen laitos, Helsingfors universitet, medicinska fakulteten, institutionen för klinisk medicin, University of Helsinki, Faculty of Medicine, Institute of Clinical Medicine, Department of Obstetrics and Gynaecology, Mass Screening Registry, Finnish Cancer Registry, and Virtanen, Anni
- Abstract
High coverage amongst those at risk and a high attendance rate are essential in achieving a good impact in a cervical cancer screening programme. In Finland, attendance in the programme is approximately 70% with a slight decreasing trend. There is wide variation in the current invitation practice between municipalities. The introduction of human papillomavirus (HPV) testing in cervical cancer screening has brought about a new possible means of improving attendance rates, as HPV-testing can be performed on self-collected samples. This offers the opportunity to supply sampling devices directly to the homes of the women (self-sampling). The aim of this study was to investigate the effects and feasibility of using self-taken samples for HPV-testing to conduct cervical cancer screening of non-attendees to the Finnish cervical screening programme. The effect on attendance to the screening programme, on overall screening test coverage (including also testing outside the screening programme), on the yield of precancerous lesions detected by screening and on the costs of a screening programme were assessed, as were women s views on this new screening modality. The effects of self-sampling were first studied as a first reminder (i.e. among non-attendees after the primary invitation) in a randomized setting in comparison to a reminder letter, and then in a non-randomized setting as a second reminder after two invitation letters. As a first reminder to non-attendees after the primary invitation, a self-sampling test resulted in somewhat higher attendance than a reminder letter. The difference was small, and in terms of resulting costs (price per extra screened woman and price per detected CIN2+ lesion), a reminder letter with a pre-assigned appointment time is a more feasible choice than a self-sampling test. However, self-sampling can be used to increase screening attendance as a second reminder after two invitation letters. Overall attendance rates increased by 4-8%, and the, Kohdunkaulan syövän seulontaohjelman tehokkuuteen vaikuttaa ohjelman peittävyyden sekä diagnostiikan ja hoidon laadun lisäksi ennen kaikkea osallistumisaktiivisuus. Suomessa joukkotarkastuksiin osallistuu nykyisin alle 70 % kutsutuista. Kuntien kutsukäytännöissä on varsin suuria eroja. Uusi mahdollisuus parantaa seulonnan osallistuvuutta ovat naisten itse kotona ottamat näytteet, joista laboratoriossa tehdään papilloomavirus (HPV) -testi. Tässä väitöskirjatutkimuksessa selvitettiin mahdollisuutta käyttää kotona tapahtuvaa näytteenottoa ensimmäistä kertaa Suomen seulontaohjelmassa. Seulontaan osallistumattomille naisille lähetettiin kotiin näytteenottoväline, ja seurattiin menetelmän vaikutuksia seulontaohjelman osallistuvuuteen, seulontatestien peittävyyteen (sisältäen myös ohjelman ulkopuoliset näytteet) ja seulonnassa todettujen syövän esiasteiden määrään. Lisäksi selvitettiin vaikutuksia kustannuksiin ja naisten kokemuksia tästä uudesta seulontatavasta. Tutkimuksen ensimmäisessä osassa näytteenottoväline lähetettiin ensimmäisen kutsun jälkeen osallistumattomille naisille ja menetelmää verrattiin satunnaistetussa asetelmassa kirjalliseen uusintakutsuun. Kotinäytteenotolla saavutettiin hieman korkeampi osallistuvuus kuin kirjallisella uusintakutsulla osallistuvuus nousi uusintakutsulla 6-14 % ja kotinäytteenotolla 17 %. Ero kokonaisosallistuvuudessa jäi kuitenkin niin pieneksi, että kotinäytteenoton korkeammat kustannukset eivät tasoittuneet. Kotinäytteenottoa voidaan kuitenkin suositella käytettäväksi kolmantena kutsuna niille, jotka eivät ole osallistuneet kahden kirjallisen kutsun jälkeen. Näin käytettynä osallistuvuus nousi kotitestillä 4 8 %, ja uusintakutsulla ja kotitestillä yhteensä 12 23 %. Samalla seulonnassa todettujen esiasteiden määrä lisääntyi 25 33 %. Valtaosa kotinäytteellä seulontaan osallistuneista oli kuitenkin käynyt lähiaikoina seulontaohjelman ulkopuolella Papa-kokeessa, joten vaikutukset testien kokonaispeittävyyteen jäivät pienemmiksi kuin o
- Published
- 2015
16. Metabolic and Hormonal Factors Related to Hypertensive Pregnancy : Special Attention to Insulin Resistance, Sympathetic Over-activity, and Hyperandrogenism
- Author
-
Helsingin yliopisto, lääketieteellinen tiedekunta, kliininen laitos, Helsingfors universitet, medicinska fakulteten, institutionen för klinisk medicin, University of Helsinki, Faculty of Medicine, Institute of Clinical Medicine, Department of Obstetrics and Gynaecology, Tuuri, Anna, Helsingin yliopisto, lääketieteellinen tiedekunta, kliininen laitos, Helsingfors universitet, medicinska fakulteten, institutionen för klinisk medicin, University of Helsinki, Faculty of Medicine, Institute of Clinical Medicine, Department of Obstetrics and Gynaecology, and Tuuri, Anna
- Abstract
Hypertension is a common medical problem encountered during pregnancy. New-onset hypertension, pregnancy-induced hypertension (PIH) with (pre-eclampsia) or without proteinuria develops in previously normotensive women. PIH has been found to be a state of insulin resistance and sympathetic over-activity. Angiopoietin-like protein 6 (Angptl6) and adipocyte fatty acid-binding protein 4 (FABP4) seem to be insulin-sensitivity regulators and they could serve as insulin sensitivity biomarkers before and during complicated pregnancy. This study consists of five sub-studies with four different study populations. In the first and second prospective observational studies there were 72 relatively overweight (BMI more or as much as 24 kg/m2) nulliparous women. In the study we assessed at 24 and/or 32 weeks of gestation predictive parameters associated with subsequent pre-eclampsia. Insulin sensitivity was assessed via the Matsuda insulin sensitivity index (ISI) and by way of homeostatic model assessment of insulin resistance (HOMA-IR). Maternal serum levels of FABP4, high sensitivity C-reactive protein (hs-CRP), androgens, and plasma noradrenaline levels were determined. In a subgroup of 47 women, serum concentrations of Angptl6 were quantified. In the third study blood pressure was measured in different body positions and sympathetic activity was assessed by way of noradrenaline and adrenaline levels for 36 women. In the fourth study diurnal blood glucose profiles were assessed in 178 women with gestational diabetes mellitus (GDM). In the fifth study, 37 women with a history of pre-eclamptic or with prior normotensive first pregnancies were studied 23 24 years after delivery. Insulin sensitivity was assessed via the Matsuda whole-body ISI and serum concentrations of androgens were assessed. Relatively overweight women who subsequently developed PIH had no evidence of insulin resistance, hyperandrogenism or inflammation at 24 or 32 weeks of gestation compared with those who rema, Koholla oleva verenpaine on yleinen raskautta komplisoiva tila. Raskaus voi indusoida aiemmin terveellä naisella verenpaineen nousun, johon liittyy virtsan valkuaista (pre-eklampsia) tai verenpaineen nousun ilman virtsaan erittyvää valkuaista. Raskauden indusoiman verenpainetaudin taustalla on havaittu olevan metabolisia tekijöitä, kuten lisääntynyt insuliiniresistenssi (IR), ja merkkejä sympaattisen hermoston yliaktiivisuudesta. Angiopoietiinin kaltainen proteiini 6 (Angptl6) ja rasvasolujen rasvahappojen sitojaproteiini 4 (FABP4) ovat uusia insuliiniherkkyyteen vaikuttavia proteiineja, jotka voivat toimia insuliiniherkkyyden biomarkkereina ennen komplisoitunutta raskautta tai sen aikana. Väitöskirjatyö koostui viidestä osatyöstä. Ensimmäisessä prospektiivisessa seurantatutkimuk-sessa oli 72 suhteellisen ylipainoista (BMI enemmän tai yhtä paljon kuin 24 kg/m2) ensisynnyttäjää, joilla oli lisääntynyt riski sairastua raskauden indusoimaan verenpainehäiriöön. Heidän insuliiniherkkyytensä määritettiin 24. raskausviikolla. Raskausviikoilla 24. ja 32. määritettiin seerumin FABP4-tasot, tutkittiin onko naisilla merkkejä sympaattisen hermoston yliaktiivisuudesta tai inflammaatiosta. Toisessa osatyössä määritettiin 47 naisen alaryhmässä seerumin Angptl6-tasot 24. ja 32. raskausviikoilla. Kolmannessa osatyössä tutkittiin 36 naisella asennonmuutoksen vaikutusta sympaattisen hermoston aktiivisuuteen pre-eklamptisessa raskaudessa. Neljännessä osatyössä tutkittiin verenpainehäiriön vaikutusta 178 raskausdiabeetikon verensokerin vuorokausikäyrään. Viidennessä tapaus-verrokki -tutkimuksessa oli 37 premenopausaalista naista, jotka tutkittiin 23 - 24 vuotta joko pre-eklamptisen tai normotensiivisen ensimmäisen raskauden jälkeen. Heidän androgeeni-pitoisuutensa analysoitiin, insuliiniherkkyytensä mitattiin ja tutkittiin metabolisen ja polykystisten munasarjojen oireyhtymän esiintyvyys. Suhteellisen ylipainoisilla raskauden aikaiseen verenpainehäiriöön sairastuneilla naisilla ei ole m
- Published
- 2014
17. Customised symphysio fundal height charts
- Author
-
Shamawama, KHB; Obstetrics and Gynaecology Unit, Teaching Hospital, Mahamodara, Galle, Goonewardene, IMR; Obstetrics and Gynaecology Unit, Teaching Hospital, Mahamodara, Galle, Perera, YAG; Department of Obstetrics and Gynaecology, University of Ruhuna, Faculty of Medicine, Galle, Shamawama, KHB; Obstetrics and Gynaecology Unit, Teaching Hospital, Mahamodara, Galle, Goonewardene, IMR; Obstetrics and Gynaecology Unit, Teaching Hospital, Mahamodara, Galle, and Perera, YAG; Department of Obstetrics and Gynaecology, University of Ruhuna, Faculty of Medicine, Galle
- Abstract
Objectives To evaluate the feasibility, applicability and the value of customised symphysio fundal height (SFH) charts developed for women of Indian origin in the United Kingdom (UK: CSFH – In chart) and women of African origin in the UK (CSFH – Af chart) in detecting fetal growth restriction and predicting low birth weight (LBW) of the neonate in a Lankan population, and to compare these results with the results obtained from the SFH chart currently used in Sri Lanka (FHB chart) and another SFH chart which uses a range of plus or minus 2-3 cm of the value of the gestational age in weeks as the reference range (GA ± 2 to 3 cm chart). Methods Pregnant women (n = 416) with confirmed periods of gestation (POG) of <22 weeks and having a singleton fetus and with no obstetric complications, had their age, parity, POG and Body Mass Index (BMI) documented. Their SFH were measured at four weekly, fortnightly and weekly intervals between 20 - 28, 28 - 36 and 37 - 41 weeks respectively and plotted on the CSFH – In chart, CSFH – Af chart, FHB chart and the GA ± 2 to 3 cm chart. The gestational age at delivery and the birth weight were recorded. Pre term deliveries were excluded leaving 401 participants for analysis. Results There were 164 (39.4 %) primigravidae, 76 (18.9 %) had low BMI and 71 (17.7 %) had a high BMI. Maternal BMI at booking was positively correlated to the birth weight of the baby but not the parity. In detecting LBW at term, the CSFH – In chart had the best sensitivity, specificity, positive predictive value, negative predictive value, and the likelihood ratios. Of the two non customised charts the GA ± 2 to 3 cm chart was better than the FHB chart. Conclusions Until a customised SFH chart is developed for Sri Lanka, the CSFH – In chart or the GA ± 2 to 3 cm chart should be used for antenatal monitoring of fetal growth. DOI: http://dx.doi.org/10.4038/cmj.v57i4.5084 Ceylon Medical Journal 2012; 57: 159-165
- Published
- 2013
18. Screening characteristics for the diagnosis of genital infections with Chlamydia trachomatis in pregnant women
- Author
-
Chulalongkorn University. Department of Obstetrics and Gynaecology, Pichai Chotnopparatpattara, Sompop Limpongsanurak, Surasith Chaithongwongwatthana, Chulalongkorn University. Department of Obstetrics and Gynaecology, Pichai Chotnopparatpattara, Sompop Limpongsanurak, and Surasith Chaithongwongwatthana
- Published
- 2006
19. Monoclonal antibodies to human sperm antigens
- Author
-
Department of Obstetrics and Gynecology, University of Michigan Medical Center, Ann Arbor, Mich., U.S.A., Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada, Cancer Research Center, University of North Carolina, Chapel Hill, N.C., U.S.A., Chi-Yu Gregory Lee, Huang, Yuan-Shen, Huang, Chien-Hwai, Ping-C. Hu, Menge, Alan C., Department of Obstetrics and Gynecology, University of Michigan Medical Center, Ann Arbor, Mich., U.S.A., Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada, Cancer Research Center, University of North Carolina, Chapel Hill, N.C., U.S.A., Chi-Yu Gregory Lee, Huang, Yuan-Shen, Huang, Chien-Hwai, Ping-C. Hu, and Menge, Alan C.
- Abstract
To elucidate the molecular nature of human sperm autoantigens, attempts were made to raise monoclonal antibodies against these antigens by hybridoma techniques. After successive immunizations with the particulate fractions of human sperm extract in BALB/c mice, the spleen cells were fused with P3-X63-Ag8 myeloma cells. Several clones and their subclones were obtained and shown by microplate radioimmunoassay to produce antibodies against human sperm antigens. When SDS gel/protein blot radioimmunobinding was used for further molecular analysis, three independently derived clones were shown to produce antibodies, all of which cross-reacted with the same two human sperm antigens with a molecular weight of about 10 000. Using an indirect immunofluorescence assay, antibodies produced by these clones were shown to react with antigens localized on the acrosomal regions of human spermatozoa. Monoclonal antibodies produced by other clones, however, showed no cross-reactivity with any of the blotted proteins from SDS gels of human spermatozoa. Some possible reasons for this are presented.
- Published
- 2006
20. Reasons, fears, and emotions behind induced abortions in Accra, Ghana
- Author
-
Adanu, Richard MK; Department of Obstetrics and Gynaecology, University of Ghana Medical School, Accra, Tweneboah, Elaine; Centre for Social Policy Studies, University of Ghana, Legon, Adanu, Richard MK; Department of Obstetrics and Gynaecology, University of Ghana Medical School, Accra, and Tweneboah, Elaine; Centre for Social Policy Studies, University of Ghana, Legon
- Abstract
Induced abortion is reported to be the third leading cause of maternal mortality worldwide. Accra being a capital city with its accompanying problems of rapid population increases and issues of migration also has its own problems with abortion. Figures from the Obstetrics and Gynaecology unit of Korle Bu Teaching Hospital in Accra give abortion as the third leading cause of maternal mortality. However, data from the Pathology unit of the same hospital, show induced abortion as the leading cause of maternal mortality in Accra. This study looks into an aspect of abortion that has been little studied ─ the reasons behind induced abortions. Institute of African Studies: Research Review Vol. 20(2) 2004: 1-9
- Published
- 2005
21. Congenital malaria in Calabar, Cross River State, Nigeria
- Author
-
Bassey, AE; Department of Paediatrics, Faculty of Clinical Sciences, College of Medical Sciences, University of Calabar, Ejezie, GC; Department of Medical Microbiology/Parasitology, Faculty of Laboratory and Allied Health Sciences, College of Medical Sciences, University of Calabar, Alaribe, AA; Department of Medical Microbiology/Parasitology, Faculty of Laboratory and Allied Health Sciences, College of Medical Sciences, University of Calabar, Useh, MF; Department of Medical Microbiology/Parasitology, Faculty of Laboratory and Allied Health Sciences, College of Medical Sciences, University of Calabar, Udo, JJ; Department of Paediatrics, Faculty of Clinical Sciences, College of Medical Sciences, University of Calabar, Ekanem, AD; Department of Obstetrics and Gynaecology, Faculty of Clinical Sciences, College of Medical Sciences, University of Calabar, Bassey, AE; Department of Paediatrics, Faculty of Clinical Sciences, College of Medical Sciences, University of Calabar, Ejezie, GC; Department of Medical Microbiology/Parasitology, Faculty of Laboratory and Allied Health Sciences, College of Medical Sciences, University of Calabar, Alaribe, AA; Department of Medical Microbiology/Parasitology, Faculty of Laboratory and Allied Health Sciences, College of Medical Sciences, University of Calabar, Useh, MF; Department of Medical Microbiology/Parasitology, Faculty of Laboratory and Allied Health Sciences, College of Medical Sciences, University of Calabar, Udo, JJ; Department of Paediatrics, Faculty of Clinical Sciences, College of Medical Sciences, University of Calabar, and Ekanem, AD; Department of Obstetrics and Gynaecology, Faculty of Clinical Sciences, College of Medical Sciences, University of Calabar
- Abstract
We recruited 600 pregnant women, whose ages were between 17 and 40 years in Calabar, Nigeria, out of which 300 of them who picked up folded pieces of paper marked \'Yes\' for themselves and their neonates were selected. The remaining 300 pregnant women who picked up the folded pieces of paper marked \'No\' for themselves and their neonates were excluded. Thereafter, we examined 300 blood samples each from the selected mothers, placenta, cord and neonates aged between 1 and 8 days for the presence of malaria parasites. The prevalence rate of 3.0% (9) for Plasmodium falciparum was observed in the neonates while 3.3%(10), 10.3% (31) and 17.0% (51) were observed in the cord, placenta and mothers respectively. The prevalence rates of infection of the neonates and cord were not statistically significant (P > 0.05) whereas statistically significant (P < 0.05) differences occurred between prevalence rates of infection of the mothers and the placenta. The infection of gametocytes only was 6% (18) and 1.3% (4) in mothers and placenta respectively. Both gametocytes and trophozoites infections were observed in 0.3% (1) maternal blood. No gametocytes or mixed infections were observed in the cord and neonates. No statistically significant differences (P > 0.05) occurred in the tissues infected with various stages of Plasmodium falciparum. The study has confirmed congenital malaria transmission in Calabar. Keywords: congenital malaria, prevalence, placenta, cord, neonatal blood Mary Slessor Journal of Medicine Vol. 5(1), 2005: 37-40
- Published
- 2005
22. Prospective Recurrent Pregnancy Loss Registry
- Author
-
Mohamed Bedaiwy, Principal Investigator, Professor and Head Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, University of British Columbia
- Published
- 2024
23. Vaginal Prolapse Pessary Material Trial PVC vs Silicon
- Author
-
Lo Cheuk Yin, Resident, Department of Obstetrics and Gynaecology
- Published
- 2024
24. Neurolinguistic Programming, Progressive Muscle Relaxation Exercises, and Breastfeeding
- Author
-
Aysegul Kilicli, Gaziantep University Health Sciences Enstıtute, Department of Nursing, Department of Obstetrics and Gynaecology Nursing, PhD.
- Published
- 2024
25. Neurolinguistic Programming on Labor Pain
- Author
-
Aysegul Kilicli, Gaziantep University Health Sciences Institute, Department of Nursing, Department of Obstetrics and Gynaecology Nursing, PhD.
- Published
- 2024
26. One-Step Directional Cloning of Blunt-Ended Polymerase Chain Reaction Products
- Author
-
Liu, Vincent W.S., Nagley, Phillip, and Ngan, Hextan Y.S.
- Published
- 2000
- Full Text
- View/download PDF
27. Yoga Nidra and Pain After Caesarean Section
- Author
-
Aysegul Kilicli, Gaziantep University Health Sciences Institute, Department of Nursing, Department of Obstetrics and Gynaecology Nursing, PhD.
- Published
- 2023
28. Effectiveness and Safety of Niraparib as First-line Maintenance Therapy for Ovarian Cancer: a Real-world Study
- Author
-
Yang Shen, Department of Obstetrics and Gynaecology, Zhongda Hospital, School of Medicine, Southeast University
- Published
- 2023
29. Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer
- Author
-
Lombaers, Marike, Cornel, Karlijn M. C., Visser, Nicole, Bulten, Johan, Küsters-Vandevelde, Heidi V. N., Amant, Frédéric, Colás Ortega, Eva, Gil-Moreno, Antonio, Institut Català de la Salut, [Lombaers MS] Department of Obstetrics and Gynaecology, Radboud University Medical Center, GA Nijmegen, The Netherlands. Radboud Institute of Health Sciences, GA Nijmegen, The Netherlands. [Cornel KMC] Department of Obstetrics and Gynaecology, Radboud University Medical Center, GA Nijmegen, The Netherlands. Department of Obstetrics and Gynecology, Division Gynecologic Oncology, University of Toronto, Toronto, Canada. [Visser NCM] Department of Pathology, Eurofins PAMM, Eindhoven, The Netherlands. [Bulten J] Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands. [Küsters-Vandevelde HVN] Department of Pathology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands. [Amant F] Department of Oncology, KU Leuven, Leuven, Belgium. Center for Gynecologic Oncology Amsterdam, Netherlands Cancer Institute and Amsterdam University Medical Center, Amsterdam, The Netherlands. [Colas E] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red Cáncer, Barcelona, Spain. [Gil-Moreno A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red Cáncer, Barcelona, Spain. Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red Cáncer, Barcelona, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
Marcadors tumorals ,factores biológicos::biomarcadores::marcadores tumorales [COMPUESTOS QUÍMICOS Y DROGAS] ,Endometri - Càncer ,Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Endometrial Neoplasms [DISEASES] ,Biological Factors::Biomarkers::Biomarkers, Tumor [CHEMICALS AND DRUGS] ,neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas::neoplasias endometriales [ENFERMEDADES] - Abstract
Advanced stage; Endometrial cancer; Outcome Etapa avançada; Càncer d'endometri; Resultat Etapa avanzada; Cáncer de endometrio; Resultado Patients with high-grade endometrial carcinoma (EC) have an increased risk of tumor spread and lymph node metastasis (LNM). Preoperative imaging and CA125 can be used in work-up. As data on cancer antigen 125 (CA125) in high-grade EC are limited, we aimed to study primarily the predictive value of CA125, and secondarily the contributive value of computed tomography (CT) for advanced stage and LNM. Patients with high-grade EC (n = 333) and available preoperative CA125 were included retrospectively. The association of CA125 and CT findings with LNM was analyzed by logistic regression. Elevated CA125 ((>35 U/mL), (35.2% (68/193)) was significantly associated with stage III-IV disease (60.3% (41/68)) compared with normal CA125 (20.8% (26/125), [p < 0.001]), and with reduced disease-specific—(DSS) (p < 0.001) and overall survival (OS) (p < 0.001). The overall accuracy of predicting LNM by CT resulted in an area under the curve (AUC) of 0.623 (p < 0.001) independent of CA125. Stratification by CA125 resulted in an AUC of 0.484 (normal), and 0.660 (elevated). In multivariate analysis elevated CA125, non-endometrioid histology, pathological deep myometrial invasion ≥50%, and cervical involvement were significant predictors of LNM, whereas suspected LNM on CT was not. This shows that elevated CA125 is a relevant independent predictor of advanced stage and outcome specifically in high-grade EC.
- Published
- 2023
30. Menarche when and why?
- Author
-
ReesNuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital Oxford, UK, Margaret
- Subjects
- *
MENARCHE - Abstract
Discusses the trend in earlier menarche. Menarche as indication of the capacity to reproduce; Improvement in health and environmental conditions; Numerous factors that determine the age of menarche.
- Published
- 1993
- Full Text
- View/download PDF
31. Immunogenicity Against SARS-CoV-2 in COVID-19 Close Contacts
- Author
-
Lan Ngoc Vuong, Head of Department of Obstetrics and Gynaecology; Dean, Faculty of Medicine
- Published
- 2021
32. Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9 (HOPE9)
- Author
-
Alessandro Ghelardi, Principal Investigator, Department of Obstetrics and Gynaecology Azienda USL Toscana Nord Ovest, Presidio Ospedaliero delle Apuane (MS)- Italy
- Published
- 2020
33. Low Dose Magnesium Sulphate Versus Standard Pritchard Regimen In Management Of Severe Preeclampsia/Eclampsia
- Author
-
Adebayo Joshua Adeniyi, Doctor, Consultant, Department of Obstetrics and Gynaecology, Principal Investigator
- Published
- 2020
34. Efficacy of Nifedipine Versus Hydralazine in Management of Severe Hypertension in Pregnancy
- Author
-
Adebayo Joshua Adeniyi, Doctor, Senior Registrar, Department of Obstetrics and Gynaecology, Principal Investigator
- Published
- 2020
35. The Use of Music in Reducing Pain During Outpatient Hysteroscopy
- Author
-
Law Ho Ying, Resident, Department of Obstetrics and Gynaecology
- Published
- 2020
36. The amount of preoperative endometrial tissue surface in relation to final endometrial cancer classification
- Author
-
Vrede, Stephanie W., Hulsman, Anneloes M.C., Reijnen, Casper, van de Vijver, Koen K.B.T., Colas, Eva, Mancebo Moreno, Gemma, Moiola, Cristian Pablo, Gil-Moreno, Antonio, Huvila, Jutta, Koskas, Martin, Weinberger, Vit, Minář, Luboš, Jandáková, Eva, Santacana, Maria, Matias-Guiu, Xavier, Amant, Frédéric, Snijders, Marc P.L.M., Küsters-Vandevelde, Heidi V.N., ENITEC-Consortium, Bulten, Johan Hans, Pijnenborg, Johanna M.A., Institut Català de la Salut, [Vrede SW] Department of Obstetrics and Gynaecology, Radboud university medical center, Nijmegen, the Netherlands. Department of Obstetrics and Gynaecology, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands. [Hulsman AMC] Department of Obstetrics and Gynaecology, Radboud university medical center, Nijmegen, the Netherlands. [Reijnen C] Department of Radiation Oncology, Radboud university medical center, Nijmegen, the Netherlands. [Van de Vijver K] Department of Pathology, Ghent University Hospital, Cancer Research Institute Ghent (CRIG), Ghent, Belgium. [Colas E, Moiola CP] Grup de Recerca Biomèdica en Ginecologia, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBERONC, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Mancebo G] Department of Obstetrics and Gynaecology, Hosepital del Mar, PSMAR, Barcelona, Spain. [Gil-Moreno A] Servei de Ginecologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Servei d’Anatomia Patològica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. CIBERONC, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Amsterdam Reproduction & Development (AR&D), Obstetrics and Gynaecology, and CCA - Imaging and biomarkers
- Subjects
Endometri - Càncer - Cirurgia ,Cura preoperatòria ,Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Techniques, Obstetrical and Gynecological::Hysteroscopy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT] ,Therapeutics::Patient Care::Preoperative Care [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT] ,Obstetrics and Gynecology ,Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Endometrial Neoplasms [DISEASES] ,Otros calificadores::Otros calificadores::/cirugía [Otros calificadores] ,Endometrial carcinoma ,Endometrial sampling ,Women's cancers Radboud Institute for Health Sciences [Radboudumc 17] ,Histeroscòpia ,Other subheadings::Other subheadings::/surgery [Other subheadings] ,All institutes and research themes of the Radboud University Medical Center ,diagnóstico::técnicas y procedimientos diagnósticos::técnicas diagnósticas obstétricas y ginecológicas::histeroscopia [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS] ,Oncology ,terapéutica::asistencia al paciente::asistencia preoperatoria [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS] ,Diagnosis ,Pathology ,Concordant ,Discordant ,neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas::neoplasias endometriales [ENFERMEDADES] - Abstract
Diagnosis; Endometrial carcinoma; Endometrial sampling Diagnóstico; Carcinoma de endometrio; Muestreo endometrial Diagnòstic; Carcinoma endometrial; Mostreig endometrial Objective To evaluate whether the amount of preoperative endometrial tissue surface is related to the degree of concordance with final low- and high-grade endometrial cancer (EC). In addition, to determine whether discordance is influenced by sampling method and impacts outcome. Methods A retrospective cohort study within the European Network for Individualized Treatment of Endometrial Cancer (ENITEC). Surface of preoperative endometrial tissue samples was digitally calculated using ImageJ. Tumor samples were classified into low-grade (grade 1–2 endometrioid EC (EEC)) and high-grade (grade 3 EEC + non-endometroid EC). Results The study cohort included 573 tumor samples. Overall concordance between pre- and postoperative diagnosis was 60.0%, and 88.8% when classified into low- and high-grade EC. Upgrading (preoperative low-grade, postoperative high-grade EC) was found in 7.8% and downgrading (preoperative high-grade, postoperative low-grade EC) in 26.7%. The median endometrial tissue surface was significantly lower in concordant diagnoses when compared to discordant diagnoses, respectively 18.7 mm2 and 23.5 mm2 (P = 0.022). Sampling method did not influence the concordance in tumor classification. Patients with preoperative high-grade and postoperative low-grade showed significant lower DSS compared to patients with concordant low-grade EC (P = 0.039). Conclusion The amount of preoperative endometrial tissue surface was inversely related to the degree of concordance with final tumor low- and high-grade. Obtaining higher amount of preoperative endometrial tissue surface does not increase the concordance between pre- and postoperative low- and high-grade diagnosis in EC. Awareness of clinically relevant down- and upgrading is crucial to reduce subsequent over- or undertreatment with impact on outcome.
- Published
- 2022
37. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions
- Author
-
Mario Preti, Elmar Joura, Pedro Vieira-Baptista, Marc Van Beurden, Federica Bevilacqua, Maaike C G Bleeker, Jacob Bornstein, Xavier Carcopino, Cyrus Chargari, Margaret E Cruickshank, Bilal Emre Erzeneoglu, Niccolò Gallio, Debra Heller, Vesna Kesic, Olaf Reich, Colleen K Stockdale, Bilal Esat Temiz, Linn Woelber, François Planchamp, Jana Zodzika, Denis Querleu, Murat Gultekin, Pathology, CCA - Cancer Treatment and quality of life, Department of Surgical Sciences, University of Torino, Torino, Italy., Medizinische Universität Wien = Medical University of Vienna, Hospital Lusiadas Porto, Porto, Portugal, Lower Genital Tract Unit, Centro Hospitalar de São João, Porto, Portugal., Centre for Gynecological Oncology Amsterdam, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Galilee Medical Center and Azrieli Faculty of Medicine, Bar-Ilan, Israel., Service de gynécologie-obstétrique [Hôpital Nord - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital Nord [CHU - APHM], Institut méditerranéen de biodiversité et d'écologie marine et continentale (IMBE), Avignon Université (AU)-Aix Marseille Université (AMU)-Institut de recherche pour le développement [IRD] : UMR237-Centre National de la Recherche Scientifique (CNRS), Département de radiothérapie [Gustave Roussy], Institut Gustave Roussy (IGR), Aberdeen Centre for Women's Health Research, University of Aberdeen, Aberdeen, UK., Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Gynaecological Oncology, Hacettepe University, Ankara, Turkey., Rutgers New Jersey Medical School, Newark, NJ, USA, Department of Obstetrics and Gynecology, University of Belgrade, Belgrade, Serbia., Department of Obstetrics and Gynecology, Medical University of Graz, Auenbruggerplatz 14, 8036 Graz, Austria., Department of Obstetrics & Gynecology, University of Iowa, Iowa City, Iowa, USA., Department of Gynecology, Hamburg-Eppendorf University Medical Center, Dysplasia Center Hamburg, Jerusalem Hospital, Hamburg, Germany., Clinical Research Unit, Institut Bergonie, Bordeaux, France., Department of Obstetrics and Gynaecology Rīga Stradiņš university, Riga, Latvia., Department of Obstetrics and Gynecologic Oncology, University Hospital, Strasbourg, France, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy., Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, Hacettepe University Faculty of Medicine, Ankara, Turkey., Aberdeen Centre for Women's Health Research, University of Aberdeen, Aberdeen, United Kingdom., Rutgers New Jersey Medical School, Newark, NJ, and Department of Obstetrics & Gynecology, University of Iowa, Iowa City, IA.
- Subjects
[SDV.EE.SANT]Life Sciences [q-bio]/Ecology, environment/Health ,Imiquimod ,Skin Neoplasms ,Vulvar Neoplasms ,Genital Neoplasms, Female ,Squamous Intraepithelial Lesions ,Paget Disease ,Obstetrics and Gynecology ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,General Medicine ,Vulvar and Vaginal Cancer ,[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics ,Paget Disease, Extramammary ,Oncology ,Colposcopy ,Pregnancy ,Extramammary ,Humans ,Female ,Melanoma ,Carcinoma in Situ ,Cidofovir - Abstract
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) developed consensus statements on pre-invasive vulvar lesions in order to improve the quality of care for patients with vaginal intraepithelial neoplasia (VaIN). The management of VaIN varies according to the grade of the lesion: VaIN 1 (low grade vaginal squamous intraepithelial lesions (SIL)) can be subjected to follow-up, while VaIN 2–3 (high-grade vaginal SIL) should be treated. Treatment needs individualization according to the patient’s characteristics, disease extension and previous therapeutic procedures. Surgical excision is the mainstay of treatment and should be performed if invasion cannot be excluded. Total vaginectomy is used only in highly selected cases of extensive and persistent disease. Carbon dioxide (CO2) laser may be used as both an ablation method and an excisional one. Reported cure rates after laser excision and laser ablation are similar. Topical agents are useful for persistent, multifocal lesions or for patients who cannot undergo surgical treatment. Imiquimod was associated with the lowest recurrence rate, highest human papillomavirus (HPV) clearance, and can be considered the best topical approach. Trichloroacetic acid and 5-fluorouracil are historical options and should be discouraged. For VaIN after hysterectomy for cervical intraepithelial neoplasia (CIN) 3, laser vaporization and topical agents are not the best options, since they cannot reach epithelium buried in the vaginal scar. In these cases surgical options are preferable. Brachytherapy has a high overall success rate but due to late side effects should be reserved for poor surgical candidates, having multifocal disease, and with failed prior treatments. VaIN tends to recur and ensuring patient adherence to close follow-up visits is of the utmost importance. The first evaluation should be performed at 6 months with cytology and an HPV test during 2 years and annually thereafter. The implementation of vaccination against HPV infection is expected to contribute to the prevention of VaIN and thus cancer of the vagina. The effects of treatment can have an impact on quality of life and result in psychological and psychosexual issues which should be addressed. Patients with VaIN need clear and up-to-date information on a range of treatment options including risks and benefits, as well as the need for follow-up and the risk of recurrence.
- Published
- 2022
- Full Text
- View/download PDF
38. High Volume Foleys Increasing Vaginal Birth Pilot Trial
- Author
-
AFP Innovation Fund and Dr. Anne Berndl, Assistant Professor University of Toronto Division of Maternal Fetal Medicine Department of Obstetrics and Gynaecology, Associate Scientist, Sunnybrook Research Institute
- Published
- 2019
39. Options for triage and implications for colposcopists within European HPV-based cervical screening programmes
- Author
-
Xavier Carcopino, Christine Bergeron, Remi Alalade, Neelam Singh, Pekka Nieminen, Margaret E. Cruickshank, Simon Leeson, Department of Obstetrics and Gynaecology, Betsi Cadwaladr University Health Board, Bangor, Gwynedd LL57 2PW, UK, University of Helsinki, Institut méditerranéen de biodiversité et d'écologie marine et continentale (IMBE), Avignon Université (AU)-Aix Marseille Université (AMU)-Institut de recherche pour le développement [IRD] : UMR237-Centre National de la Recherche Scientifique (CNRS), Laboratoire CERBA [Saint Ouen l'Aumône], Department of Obstetrics and Gynaecology, Betsi Cadwaladr University Health Board, Wales, LL57 2PW, UK, Helsingin yliopisto = Helsingfors universitet = University of Helsinki, Aberdeen Maternity Hospital, Service de gynécologie-obstétrique [Hôpital Nord - APHM], and Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital Nord [CHU - APHM]
- Subjects
Human papillomavirus ,medicine.medical_specialty ,Cost effectiveness ,[SDV]Life Sciences [q-bio] ,Population ,Uterine Cervical Neoplasms ,Cervical intraepithelial neoplasia ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,Humans ,Mass Screening ,Medicine ,030212 general & internal medicine ,education ,Papillomaviridae ,Genotyping ,Early Detection of Cancer ,ComputingMilieux_MISCELLANEOUS ,Colposcopy ,Dual-stain cytology ,education.field_of_study ,DNA methylation ,030219 obstetrics & reproductive medicine ,Cervical screening ,Human papillomavirus 18 ,medicine.diagnostic_test ,business.industry ,Obstetrics ,Papillomavirus Infections ,HPV genotyping ,Obstetrics and Gynecology ,medicine.disease ,Triage ,3. Good health ,Squamous carcinoma ,Europe ,Reproductive Medicine ,Female ,Cytology ,business - Abstract
International audience; The development of human papillomavirus (HPV)-based screening should detect more pre-cancerous changes and so reduce the incidence and mortality from cervical squamous carcinoma and cervical adenocarcinoma. However, many more women are high risk HPV (hrHPV) screen positive compared to cytology-based screening, especially in younger age-women. A variety of tests have become available which may triage into those hrHPV test-positive women who need immediate referral to colposcopy from those who need early repeat HPV tests or recall on the basis of their disease status.We performed a literature review of publications and a manual search from 2010, reporting cytology, HPV partial genotyping, dual-staining and DNA methylation for triage of hrHPV positive tests, including their comparative performance between these methods as well as the effectiveness of some triage combinations with reference to HPV-based screening services in Europe. Cost effectiveness and the structure of triage algorithms for colposcopists also have been considered. From one report evaluating four options for triage as single options or as combined algorithms, partial genotyping for HPV 16 and 18 with dual-staining yielded the highest risk of cervical intraepithelial neoplasia grade three or worse within an HPV positive population and with an acceptable colposcopy rate. From a separate paper, this option appeared cost effective. However, publications were difficult to compare objectively.All options have their merits but a combination triage involving any two of cytology, HPV partial genotyping or dual-staining seems most efficient at present. HPV vaccination may impact upon the performance of future partial genotyping. DNA Methylation may become an acceptable future option.
- Published
- 2021
- Full Text
- View/download PDF
40. Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer
- Author
-
Vrede, S. W., Van Weelden, Willem Jan, Visser, N. C. M., Bulten, Johan, van der Putten, Louis J. M., van de Vijver, Koen, Santacana Espasa, Maria, Colàs Campàs, Laura, Gil-Moreno, Antonio, Moiola, Cristian P., Mancebo, Gemma, Krakstad, Camilla, Trovik, Jone, Haldorsen, Ingfrid S., Huvila, Jutta, Koskas, Martin, Weinberger, Vit, Bednarikova, M., Hausnerova, Jitka, van der Wurff, Anneke A. M., Matias-Guiu, Xavier, Amant, Frederic, ENITEC Consortium, Snijders, Marc P. L. M., Küsters-Vandevelde, Heidi V. N, Reijnen, Casper, Pijnenborg, Johanna M. A., Institut Català de la Salut, [Vrede SW] Department of Obstetrics and Gynaecology, Radboud university medical center, Nijmegen, the Netherlands. Department of Obstetrics and Gynaecology, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands. [van Weelden WJ, van der Putten LJM] Department of Obstetrics and Gynaecology, Radboud university medical center, Nijmegen, the Netherlands. [Visser NCM] Department of Pathology, Stichting PAMM, Eindhoven, the Netherlands. Department of Pathology, Radboud university medical center, Nijmegen, the Netherlands. [Bulten J] Department of Pathology, Radboud university medical center, Nijmegen, the Netherlands. [van de Vijver K] Department of Pathology, Ghent University Hospital, Cancer Research Institute Ghent (CRIG), Ghent, Belgium. [Colas E, Moiola CP] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBERONC, Barcelona, Spain. [Gil-Moreno A] Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBERONC, Barcelona, Spain. Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBERONC, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, CCA - Imaging and biomarkers, Obstetrics and Gynaecology, and ARD - Amsterdam Reproduction and Development
- Subjects
0301 basic medicine ,Oncology ,IMPACT ,PREDICTION ,Estrogen receptor ,factores biológicos::biomarcadores::marcadores tumorales [COMPUESTOS QUÍMICOS Y DROGAS] ,0302 clinical medicine ,STAGE ,Medicine and Health Sciences ,Medicine ,Stage (cooking) ,Lymph node ,Outcome ,Obstetrics & Gynecology ,Obstetrics and Gynecology ,Immunohistochemistry ,Women's cancers Radboud Institute for Health Sciences [Radboudumc 17] ,3. Good health ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,CELL-ADHESION MOLECULE ,SURVIVAL ,Biomarker (medicine) ,Life Sciences & Biomedicine ,EXPRESSION ,medicine.medical_specialty ,CARCINOMA ,Endometrial carcinoma ,03 medical and health sciences ,All institutes and research themes of the Radboud University Medical Center ,Internal medicine ,CURETTAGE ,Progesterone receptor ,Carcinoma ,Biological Factors::Biomarkers::Biomarkers, Tumor [CHEMICALS AND DRUGS] ,Diagnosis::Prognosis [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT] ,diagnóstico::pronóstico [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS] ,Lymph node metastasis ,Science & Technology ,Endometri - Càncer - Prognosi ,RECEPTOR ,business.industry ,Endometrial cancer ,Marcadors tumorals ,Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Endometrial Neoplasms [DISEASES] ,Biomarker ,medicine.disease ,030104 developmental biology ,L1CAM ,business ,neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas::neoplasias endometriales [ENFERMEDADES] - Abstract
Objective. Pre-operative immunohistochemical (IHC) biomarkers are not incorporated in endometrial cancer (EC) risk classification. We aim to investigate the added prognostic relevance of IHC biomarkers to the ESMOESGO-ESTRO risk classification and lymph node (LN) status in EC. Methods. Retrospective multicenter study within the European Network for Individualized Treatment of Endometrial Cancer (ENITEC), analyzing pre-operative IHC expression of p53, L1 cell-adhesion molecule (L1CAM), estrogen receptor (ER) and progesterone receptor (PR), and relate to ESMO-ESGO-ESTRO risk groups, LN status and outcome. Results. A total of 763 EC patients were included with a median follow-up of 5.5-years. Abnormal IHC expression was present for p53 in 112 (14.7%), L1CAM in 79 (10.4%), ER-in 76 (10.0%), and PR-in 138 (18.1%) patients. Abnormal expression of p53/L1CAM/ER/PR was significantly related with higher risk classification groups, and combined associated with the worst outcome within the 'high and advanced/metastatic' risk group. In multivariate analysis p53-abn, ER/PR-and ESMO-ESGO-ESTRO 'high and advanced/metastatic' were independently associated with reduced disease-specific survival (DSS). Patients with abnormal IHC expression and lymph node metastasis (LNM) had the worst outcome. Patients with LNM and normal IHC expression had comparable outcome with patients without LNM and abnormal IHC expression. Conclusion. The use of pre-operative IHC biomarkers has important prognostic relevance in addition to the ESMO-ESGO-ESTRO risk classification and in addition to LN status. For daily clinical practice, p53/L1CAM/ER/ PR expression could serve as indicator for surgical staging and refine selective adjuvant treatment by incorporation into the ESMO-ESGO-ESTRO risk classification. (c) 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/). sion was present for p53 in 112 (14.7%), L1CAM in 79 (10.4%), ER- in 76 (10.0%), and PR- in 138 (18.1%) patients. Abnormal expression of p53/L1CAM/ER/PR was significantly related with higher risk classification groups, and combined associated with the worst outcome within the 'high and advanced/metastatic' risk group. In multivariate analysis p53-abn, ER/PR- and ESMO-ESGO-ESTRO 'high and advanced/metastatic' were independently associated with reduced disease-specific survival (DSS). Patients with abnormal IHC expression and lymph node metastasis (LNM) had the worst outcome. Patients with LNM and normal IHC expression had comparable outcome with patients without LNM and abnormal IHC expression. Conclusion. The use of pre-operative IHC biomarkers has important prognostic relevance in addition to the ESMO-ESGO-ESTRO risk classification and in addition to LN status. For daily clinical practice, p53/L1CAM/ER/ PR expression could serve as indicator for surgical staging and refine selective adjuvant treatment by incorpora
- Published
- 2021
41. Psychosocial and Clinical Characteristics Predicting Women's Acceptance of Office Hysteroscopy
- Author
-
Marta Fernandes, M.D. MSc, Sonia Gonçalves, M.D, José Damasceno Costa, M.D., Antonio Pipa, M.D., Raquel Oliveira, MSc., nurse Catarina Mota, nurse Carla Santos, and Antonio paulo, Consultant Obstetrician and Gynaecologist - Department of Obstetrics and Gynaecology, Hospital Centre Tondela-Viseu Assistant Professor Health Sciences Department, University of Aveiro - Portugal
- Published
- 2017
42. Comparison of pelvic and para-aortic lymphadenectomy versus para-aortic lymphadenectomy alone for locally advanced FIGO stage IB2 to IIB cervical cancer using a propensity score matching analysis: Results from the FRANCOGYN study group
- Author
-
Emile Daraï, Florence Huguet, Marcos Ballester, Pierre Collinet, Vincent Lavoué, Geoffroy Canlorbe, Emilie Raimond, J. Varinot, Xavier Carcopino, Cyrille Huchon, Groupe de Recherche Francogyn, Lobna Ouldamer, Sofiane Bendifallah, Tiphaine de Foucher, Cyril Touboul, Alexandre Bricou, Olivier Graesslin, CHU Tenon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université Pierre et Marie Curie - Paris 6 (UPMC), Institut Universitaire de Cancérologie [Sorbonne Université] (IUC), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Department of Obstetrics and Gynaecology, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, Tours, France., Department of Obstetrics, Gynecology and Reproductive Medicine, Hôpitaux Universitaires Paris Seine Saint-Denis, Assistance Publique-Hôpitaux de Paris, France., CRLCC Eugène Marquis (CRLCC), Institut méditerranéen de biodiversité et d'écologie marine et continentale (IMBE), Avignon Université (AU)-Aix Marseille Université (AMU)-Institut de recherche pour le développement [IRD] : UMR237-Centre National de la Recherche Scientifique (CNRS), Service de gynécologie-obstétrique [Hôpital Nord - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital Nord [CHU - APHM], Department of Obstetrics and Gynaecology, Institute Alix de Champagne University Hospital, Reims, France., Department of Obstetrics and Gynecology, Centre Hospitalier Intercommunal, Créteil, France., Department of Gynecologic Surgery, Jeanne de Flandre Hospital, CHU de Lille, Lille, France., Department of Obstetrics and Gynecology, Poissy-St Germain Hospital, Poissy, France., Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut Universitaire de Cancérologie [Paris] (IUC), and Department of Obstetrics and Gynaecology, Hôpital Nord, APHM, Aix-Marseille University (AMU), CNRS, IRD, Marseille, France.
- Subjects
Adult ,medicine.medical_specialty ,Survival ,medicine.medical_treatment ,Locally advanced ,Urology ,Uterine Cervical Neoplasms ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics ,Pelvis ,03 medical and health sciences ,0302 clinical medicine ,Nodal status ,medicine ,Para aortic lymphadenectomy ,Humans ,Aorta, Abdominal ,Stage (cooking) ,Propensity Score ,Lymph node ,Aged ,Neoplasm Staging ,Cervical cancer ,Locally advanced cervical cancer ,[SDV.EE.SANT]Life Sciences [q-bio]/Ecology, environment/Health ,030219 obstetrics & reproductive medicine ,business.industry ,Lymphadenectomy ,General Medicine ,Middle Aged ,medicine.disease ,Prognosis ,humanities ,3. Good health ,Survival Rate ,MESH: Locally advanced cervical cancer ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Lymphatic Metastasis ,Propensity score matching ,Lymph Node Excision ,Surgery ,Female ,Neoplasm Recurrence, Local ,business - Abstract
Introduction Pre-treatment evaluation of nodal status is crucial in women presenting with locally advanced cervical cancer (LACC). However, the prognostic impact of surgical staging remains to be proved, as published results comparing surgical versus radiological staging are contradictory. The aim of this study was to compare the prognosis of women with FIGO stage IB2–IIB CC who underwent surgical nodal staging including either exclusive para-aortic lymphadenectomy (PAL) or comprehensive pelvic + para-aortic lymphadenectomy (P-PAL). Materials and methods Data of 314 women with FIGO stage IB2 to IIB CC treated between January 2000 and January 2015 were retrospectively abstracted from nine French institutions. The prognosis and outcomes were compared by Propensity score (PS) matching (PSM) analysis. Results The median follow-up was 33 months (2–114). When comparing women who underwent PAL vs P-PAL, the recurrence rates were 26% (37/144) and 28% (41/144), respectively (p = 0.595). The respective 3-year recurrence free survival (RFS) for P-PAL and PAL were 72.9% (95% CI, 65.7–81.0) and 70.7% (95% CI, 62.4–80.2), (p = 0.394). The respective 3-year overall survival (OS) rates for P-PAL and PAL were 86.8% (95% CI, 81.1–92.9) and 78.6% (95% CI, 70.4–87.7) (p = 0.592). In the sub-group of women with lymph node metastases, RFS was improved for women who underwent P-PAL compared to those with exclusive PAL (p = 0.027), with no difference in OS (p = 0.187). Conclusions Comprehensive P-PAL does not seem to be of significant therapeutic benefit compared to exclusive PAL.
- Published
- 2018
- Full Text
- View/download PDF
43. What gynaecologists need to master: Consensus on medical expertise outcome of pan-European postgraduate training in obstetrics and gynecology
- Author
-
Olaf Reich, Xavier Carcopino, Christine Bergeron, Ulrich Petry, Pekka Niemenen, Charles W.E. Redman, Simon Leeson, Department of Obstetrics and Gynaecology, Royal Stoke University Hospital, Stoke-on-Trent, ST4 6QG, UK, Klinikum Wolfsburg, Frauenklinik Schwerpunkt Gynäkologische Onkologie, Sauerbruchstrasse 7, 38440 Wolfsburg, Germany., Department of Obstetrics and Gynaecology, Betsi Cadwaladr University Health Board, Bangor, Gwynedd LL57 2PW, UK, Department of Obstetrics and Gynaecology [Helsinki], Faculty of Medecine [Helsinki], Helsingin yliopisto = Helsingfors universitet = University of Helsinki-Helsingin yliopisto = Helsingfors universitet = University of Helsinki, Institut méditerranéen de biodiversité et d'écologie marine et continentale (IMBE), Avignon Université (AU)-Aix Marseille Université (AMU)-Institut de recherche pour le développement [IRD] : UMR237-Centre National de la Recherche Scientifique (CNRS), Laboratoire CERBA, Laboratoire CERBA [Saint Ouen l'Aumône], Department of Obstetrics and Gynecology, Medical University of Graz, Auenbruggerplatz 14, 8036 Graz, Austria., and University of Helsinki-University of Helsinki
- Subjects
[SDV.EE.SANT]Life Sciences [q-bio]/Ecology, environment/Health ,Medical education ,business.industry ,education ,MEDLINE ,Obstetrics and Gynecology ,030204 cardiovascular system & hematology ,[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics ,Outcome (game theory) ,03 medical and health sciences ,0302 clinical medicine ,Reproductive Medicine ,Pan european ,Obstetrics and gynaecology ,Colposcopy ,Education, Medical, Graduate ,Gynecology ,Humans ,Medicine ,Female ,Clinical Competence ,030212 general & internal medicine ,Clinical competence ,business ,Postgraduate training - Abstract
International audience; Harmonisation of training standards in postgraduate Obstetric and Gynaecological Training is important but this should be not at the expense of ignoring previously agreed pan-European quality standards. The recent Delphi process jointly undertaken by the European Board & College of Obstetrics & Gynaecology (EBCOG) and the European Network of Trainees in Obstetrics and Gynaecology suggests that all gynaecological trainees should be able to perform LLETZ and conisation of the cervix. This is ill-advised.
- Published
- 2018
- Full Text
- View/download PDF
44. Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
- Author
-
Vergote, Ignace, ray coquard, isabelle, Lorusso, Domenica, OAKNIN, ANA, Cibula, David, Van Gorp, Toon, Institut Català de la Salut, [Vergote I, Van Gorp T] Department of Gynecology and Obstetrics, Gynecologic Oncology, Leuven Cancer Institute, Catholic University Leuven, Leuven, Belgium, Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium, European Union. [Ray-Coquard I] Medical Oncology Department, Centre Léon Bérard and University Claude Bernard Lyon 1, GINECO, Lyon, France. [Lorusso D] Gynecologic Oncology Unit, Catholic University of Sacred Heart and Fondazione Policlinico Gemelli IRCCS, Rome, Italy. [Oaknin A] Gynecologic Cancer Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Cibula D] Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. Central and Eastern European Gynecologic Oncology Group (CEEGOG), Prague, Czech Republic, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
Pharmacology ,Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores] ,aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::globulinas séricas::inmunoglobulinas::anticuerpos::inmunoconjugados [COMPUESTOS QUÍMICOS Y DROGAS] ,Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Serum Globulins::Immunoglobulins::Antibodies::Immunoconjugates [CHEMICALS AND DRUGS] ,General Medicine ,Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Uterine Cervical Neoplasms [DISEASES] ,Other subheadings::Other subheadings::/drug therapy [Other subheadings] ,Coll uterí - Càncer - Tractament ,Farmàcia - Investigació ,Pharmaceutical Preparations::Drugs, Investigational [CHEMICALS AND DRUGS] ,preparados farmacéuticos::fármacos en investigación [COMPUESTOS QUÍMICOS Y DROGAS] ,Pharmacology (medical) ,Immunoglobulines ,neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas::neoplasias del cuello uterino [ENFERMEDADES] - Abstract
Recurrent cervical cancer; Combination therapy; Immunotherapy Cáncer cervical recurrente; Terapia de combinación; Inmunoterapia Càncer cervical recurrent; Teràpia combinada; Immunoteràpia Introduction: Recurrent or primary advanced metastatic cervical cancer (R/M CC) has a poor prognosis with a 5-year-survival rate of 16.5%, demanding novel and improved therapies for the treatment of these patients. The first-line standard of care for R/M CC now benefits from the addition of the immune checkpoint inhibitor, pembrolizumab, to platinum-based chemotherapy with paclitaxel and bevacizumab. Additionally, new options for second-line treatment have become available in recent years. Areas covered: Here, we review current investigational drugs and discuss their relative targets, efficacies, and potential within the R/M CC treatment landscape. This review will focus on recently published data and key ongoing clinical trials in patients with R/M CC, covering multiple modes of action, including immunotherapies, antibody-drug conjugates, and tyrosine kinase inhibitors. We searched clinicaltrials.gov for ongoing trials and pubmed.ncbi.nih.gov for recently published trial data, as well as recent years' proceedings from the annual conferences of the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), European Society of Gynaecological Oncology (ESGO), and the International Gynecologic Cancer Society (IGCS). Expert opinion: Therapeutics currently attracting attention include novel immune checkpoint inhibitors, therapeutic vaccinations, antibody-drug conjugates, such as tisotumab vedotin, tyrosine kinase inhibitors targeting HER2, and multitarget synergistic combinations.
- Published
- 2023
- Full Text
- View/download PDF
45. The Study of Massively Parallel Sequencing in Early Detection for Gynecologic Malignant Tumor
- Author
-
Shenzhen Huada Genomics Co., Ltd. and Zhiqing, Liang, Department of Obstetrics and Gynaecology, Southwest Hospital
- Published
- 2014
46. Developing a knowledge base to support the annotation of ultrasound images of ectopic pregnancy
- Author
-
Dhombres, F., Maurice, P., Friszer, S., Guilbaud, L., Lelong, N., Khoshnood, B., Jean Charlet, Perrot, N., Jauniaux, E., Jurkovic, D., Jm Jouannic, Laboratoire d'Informatique Médicale et Ingénierie des Connaissances en e-Santé (LIMICS), Université Paris 13 (UP13)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Equipe 1 : EPOPé - Épidémiologie Obstétricale, Périnatale et Pédiatrique (CRESS - U1153), Université Paris Descartes - Paris 5 (UPD5)-Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), Institut National de la Recherche Agronomique (INRA)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Recherche Agronomique (INRA)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Echographie [Paris], Centre d’Imagerie Médicale Pyramides [Paris], Department of Obstetrics and Gynaecology [UCL - London, UK], University College of London [London] (UCL)-Institute for Women's Health [London, UK], Department of Obstetrics and Gynaecology [UCLH - London, UK], Gynaecology Diagnostic and Outpatient Treatment Unit [UCLH - London, UK], University College London Hospitals (UCLH)-University College London Hospitals (UCLH), The development of the web-application was founded by the SATT-Lutech for the Pierre and Marie Curie University, Paris, France., Charlet, Jean, Laboratoire d'Informatique Médicale et Ingénierie des Connaissances en e-Santé ( LIMICS ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Université Paris 13 ( UP13 ), Equipe 1 : EPOPé - Épidémiologie Obstétricale, Périnatale et Pédiatrique ( CRESS - U1153 ), Université Paris Descartes - Paris 5 ( UPD5 ) -Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité ( CRESS (U1153 / UMR_A 1125) ), Université Sorbonne Paris Cité ( USPC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Institut National de la Recherche Agronomique ( INRA ) -Université Sorbonne Paris Cité ( USPC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Institut National de la Recherche Agronomique ( INRA ), University College of London [London] ( UCL ) -Institute for Women's Health [London, UK], University College London Hospitals ( UCLH ) -University College London Hospitals ( UCLH ), Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Recherche Agronomique (INRA)-Université Paris Descartes - Paris 5 (UPD5)-Université Sorbonne Paris Cité (USPC)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Recherche Agronomique (INRA)-Université Paris Descartes - Paris 5 (UPD5)-Université Sorbonne Paris Cité (USPC), and BMC, BMC
- Subjects
[ SDV ] Life Sciences [q-bio] ,Ectopic pregnancy ,Research ,[SDV]Life Sciences [q-bio] ,Application ontology ,Pregnancy, Ectopic ,[SDV] Life Sciences [q-bio] ,Knowledge base ,Biological Ontologies ,Pregnancy ,Data Mining ,Humans ,Female ,[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM] ,Ultrasonography ,[INFO.INFO-BI] Computer Science [cs]/Bioinformatics [q-bio.QM] - Abstract
International audience; AbstractBackgroundEctopic pregnancy is a frequent early complication of pregnancy associated with significant rates of morbidly and mortality. The positive diagnosis of this condition is established through transvaginal ultrasound scanning. The timing of diagnosis depends on the operator expertise in identifying the signs of ectopic pregnancy, which varies dramatically among medical staff with heterogeneous training. Developing decision support systems in this context is expected to improve the identification of these signs and subsequently improve the quality of care. In this article, we present a new knowledge base for ectopic pregnancy, and we demonstrate its use on the annotation of clinical images.ResultsThe knowledge base is supported by an application ontology, which provides the taxonomy, the vocabulary and definitions for 24 types and 81 signs of ectopic pregnancy, 484 anatomical structures and 32 technical elements for image acquisition. The knowledge base provides a sign-centric model of the domain, with the relations of signs to ectopic pregnancy types, anatomical structures and the technical elements. The evaluation of the ontology and knowledge base demonstrated a positive feedback from a panel of 17 medical users. Leveraging these semantic resources, we developed an application for the annotation of ultrasound images. Using this application, 6 operators achieved a precision of 0.83 for the identification of signs in 208 ultrasound images corresponding to 35 clinical cases of ectopic pregnancy.ConclusionsWe developed a new ectopic pregnancy knowledge base for the annotation of ultrasound images. The use of this knowledge base for the annotation of ultrasound images of ectopic pregnancy showed promising results from the perspective of clinical decision support system development. Other gynecological disorders and fetal anomalies may benefit from our approach.
- Published
- 2016
- Full Text
- View/download PDF
47. A Comparison of Rapid Immunoassay Tests for the Detection of Ruptured Membranes
- Author
-
Professor Hemantha M. Senanayake, Professor, Department of Obstetrics and Gynaecology
- Published
- 2013
48. An EG-VEGF-dependent decrease in homeobox gene NKX3.1 contributes to cytotrophoblast dysfunction: a possible mechanism in human fetal growth restriction
- Author
-
Nadia Alfaidy, Frédéric Goffin, Vassilis Tsatsaris, Jean-Jacques Feige, Carine Munaut, Anita Pratt, Bill Kalionis, Padma Murthi, Mohamed Benharouga, Anthony J. Borg, Sophie Brouillet, Thierry Fournier, Department of Obstetrics and Gynaecology [Melbourne], Melbourne Medical School [Melbourne], Faculty of Medicine, Dentistry and Health Sciences [Melbourne], University of Melbourne-University of Melbourne-Faculty of Medicine, Dentistry and Health Sciences [Melbourne], University of Melbourne-University of Melbourne, Department of Perinatal Medicine, Royal Women's Hospital, Monash University [Clayton], Department of Medicine, Biologie du Cancer et de l'Infection (BCI ), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Pôle Couple-Enfant, Département de Génétique et Procréation, Laboratoire de Biologie des Tumeurs et du Développement), Université de Liège, La grossesse normale et pathologique: développement et fonctions du placenta et de l'utérus (UMR_S 767), Institut des sciences du Médicament -Toxicologie - Chimie - Environnement (IFR71), Institut National de la Santé et de la Recherche Médicale (INSERM)-Ecole Nationale Supérieure de Chimie de Paris - Chimie ParisTech-PSL (ENSCP), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Ecole Nationale Supérieure de Chimie de Paris - Chimie ParisTech-PSL (ENSCP), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Paris Descartes - Paris 5 (UPD5)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Maternité Port-Royal [CHU Cochin], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Laboratoire de Chimie et Biologie des Métaux (LCBM - UMR 5249), Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), PremUp Foundation, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Descartes - Paris 5 (UPD5)-CHI Créteil-Institut de Recherche pour le Développement (IRD)-Université Paris-Sud - Paris 11 (UP11)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Diderot - Paris 7 (UPD7), Physiopathologie et Pharmacotoxicologie Placentaire Humaine (U1139), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Biologie des Métaux (BioMet), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Invasion mechanisms in angiogenesis and cancer (IMAC), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), laboratory of clinical investigation III, University of Geneva [Switzerland], Department of Obstetrics and Gynaecology, University of Melbourne, Biologie du Cancer et de l'Infection ( BCI - UMR S1036 ), Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Grenoble Alpes ( UGA ), CHU de Grenoble, Hôpital Couple-Enfant, Département de Génétique et Procréation, La grossesse normale et pathologique: développement et fonctions du placenta et de l'utérus ( UMR_S 767 ), Institut des sciences du Médicament -Toxicologie - Chimie - Environnement ( IFR71 ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Ecole Nationale Supérieure de Chimie de Paris- Chimie ParisTech-PSL ( ENSCP ) -Centre National de la Recherche Scientifique ( CNRS ) -Institut de Recherche pour le Développement ( IRD ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Ecole Nationale Supérieure de Chimie de Paris- Chimie ParisTech-PSL ( ENSCP ) -Centre National de la Recherche Scientifique ( CNRS ) -Institut de Recherche pour le Développement ( IRD ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Cochin [AP-HP], Laboratoire de Chimie et Biologie des Métaux ( LCBM - UMR 5249 ), Université Joseph Fourier - Grenoble 1 ( UJF ) -Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ) -Centre National de la Recherche Scientifique ( CNRS ) -Université Grenoble Alpes ( UGA ), Institut de Recherche pour le Développement ( IRD ) -Université Paris-Sud - Paris 11 ( UP11 ) -Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Université Paris Diderot - Paris 7 ( UPD7 ) -CHI Créteil-Université Paris Descartes - Paris 5 ( UPD5 ) -Sorbonne Universités-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Physiopathologie et Pharmacotoxicologie Placentaire Humaine ( U1139 ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Paris Descartes - Paris 5 ( UPD5 ), Institut de Recherche pour le Développement (IRD)-Ecole Nationale Supérieure de Chimie de Paris - Chimie ParisTech-PSL (ENSCP), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Ecole Nationale Supérieure de Chimie de Paris - Chimie ParisTech-PSL (ENSCP), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Recherche pour le Développement (IRD)-Université Paris-Sud - Paris 11 (UP11)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Diderot - Paris 7 (UPD7)-CHI Créteil-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Grenoble Alpes (UGA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Ecole Nationale Supérieure de Chimie de Paris- Chimie ParisTech-PSL (ENSCP)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Ecole Nationale Supérieure de Chimie de Paris- Chimie ParisTech-PSL (ENSCP)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Paris Descartes - Paris 5 (UPD5)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Cochin [AP-HP], Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), and Institut de Recherche pour le Développement (IRD)-Université Paris-Sud - Paris 11 (UP11)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Diderot - Paris 7 (UPD7)-CHI Créteil-Université Paris Descartes - Paris 5 (UPD5)-Sorbonne Universités-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
MESH: Protein Structure, Quaternary ,MESH: Cricetinae ,Placental insufficiency ,Biology ,Cystic fibrosis ,Andrology ,MESH: Protein Structure, Tertiary ,chemistry.chemical_compound ,Syncytiotrophoblast ,MESH: Protein Stability ,[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN] ,Genetics ,medicine ,Quaternary structure ,MESH: Animals ,CFTR ,Membrane stability ,[ SDV.MHEP.GEO ] Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics ,[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry, Molecular Biology ,NBD2 ,Molecular Biology ,Gene ,Genetics (clinical) ,MESH: Cystic Fibrosis Transmembrane Conductance Regulator ,Messenger RNA ,MESH: Humans ,Cytotrophoblast ,[ SDV.BC ] Life Sciences [q-bio]/Cellular Biology ,Trophoblast ,[SDV.BDLR]Life Sciences [q-bio]/Reproductive Biology ,Articles ,medicine.disease ,Molecular biology ,MESH: Cell Line ,Vascular endothelial growth factor ,[ SDV.BDLR ] Life Sciences [q-bio]/Reproductive Biology ,medicine.anatomical_structure ,[SDV.BDD.EO]Life Sciences [q-bio]/Development Biology/Embryology and Organogenesis ,chemistry ,[ SDV.BDD.EO ] Life Sciences [q-bio]/Development Biology/Embryology and Organogenesis ,embryonic structures ,Molecular Medicine ,Homeobox ,Dimerization ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,MESH: Cell Membrane - Abstract
International audience; Idiopathic fetal growth restriction (FGR) is frequently associated with placental insufficiency. Previous reports have provided evidence that endocrine gland-derived vascular endothelial growth factor (EG-VEGF), a placental secreted protein, is expressed during the first trimester of pregnancy, controls both trophoblast proliferation and invasion, and its increased expression is associated with human FGR. In this study, we hypothesize that EG-VEGF-dependent changes in placental homeobox gene expressions contribute to trophoblast dysfunction in idiopathic FGR. The changes in EG-VEGF-dependent homeobox gene expressions were determined using a homeobox gene cDNA array on placental explants of 8-12 wks gestation after stimulation with EG-VEGF in vitro for 24 h. The homeobox gene array identified a greater-than-five-fold increase in HOXA9, HOXC8, HOXC10, HOXD1, HOXD8, HOXD9 and HOXD11, while NKX 3.1 showed a greater-than-two-fold decrease in mRNA expression compared with untreated controls. Homeobox gene NKX3.1 was selected as a candidate because it is a downstream target of EG-VEGF and its expression and functional roles are largely unknown in control and idiopathic FGR-affected placentae. Real-time PCR and immunoblotting showed a significant decrease in NKX3.1 mRNA and protein levels, respectively, in placentae from FGR compared with control pregnancies. Gene inactivation in vitro using short-interference RNA specific for NKX3.1 demonstrated an increase in BeWo cell differentiation and a decrease in HTR-8/SVneo proliferation. We conclude that the decreased expression of homeobox gene NKX3.1 downstream of EG-VEGF may contribute to the trophoblast dysfunction associated with idiopathic FGR pregnancies.
- Published
- 2015
- Full Text
- View/download PDF
49. Maternal risk factors associated with term low birth weight in India: A review
- Author
-
Harsh Vats, Ruchi Saxena, Mohinder P. Sachdeva, Gagandeep K. Walia, Vipin Gupta, Vats, Harsh - Department of Anthropology, University of Delhi, Delhi, Saxena, Ruchi - Department of Obstetrics and Gynaecology, Sardar Patel Medical College, Bikaner, Rajasthan, India, Sachdeva, Mohinder P. - Department of Anthropology, University of Delhi, Delhi, Walia, Gagandeep K. - Public Health Foundation of India, Gurugram, Haryana, India, Gupta, Vipin - Department of Anthropology, University of Delhi, Delhi, Vats, Harsh - vats.harsh.1994@gmail.com, Saxena, Ruchi - drgajendrasaxena@gmail.com, Sachdeva, Mohinder P. - mpsachdeva@rediffmail.com, Walia, Gagandeep K. - gkaurw@gmail.com, and Gupta, Vipin - drvipiing@gmail.com
- Subjects
anaemia ,Health (social science) ,hypertension ,maternal age ,Anthropology ,obstetric history ,gestational weight gain ,Low Birth Weight ,India ,maternal risk factors ,maternal Body Mass Index - Abstract
Low birth weight is one of the leading factors for infant morbidity and mortality. To a large extent affect, various maternal risk factors are associated with pregnancy outcomes by increasing odds of delivering an infant with low birth weight. Despite this association, understanding the maternal risk factors affecting term low birth weight has been a challenging task. To date, limited studies have been conducted in India that exert independent magnitude of these effects on term low birth weight. The aim of this review is to examine the current knowledge of maternal risk factors that contribute to term low birth weight in the Indian population. In order to identify the potentially relevant articles, an extensive literature search was conducted using PubMed, Goggle Scholar and IndMed databases (1993 – Dec 2020). Our results indicate that maternal age, educational status, socio-economic status, ethnicity, parity, pre-pregnancy weight, maternal stature, maternal body mass index, obstetric history, maternal anaemia, gestational weight gain, short pregnancy outcome, hypertension during pregnancy, infection, antepartum haemorrhage, tobacco consumption, maternal occupation, maternal psychological stress, alcohol consumption, antenatal care and mid-upper arm circumference have all independent effects on term low birth weight in the Indian population. Further, we argue that exploration for various other dimensions of maternal factors and underlying pathways can be useful for a better understanding of how it exerts independent association on term low birth weight in the Indian sub-continent.
- Published
- 2023
50. EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR)
- Author
-
Jean-Jacques Feige, Nadia Alfaidy, Mbarka Dakouane-Giudicelli, Aude Salomon, Pascale Hoffmann, Marie-Noëlle Dieudonné, Sophie Brouillet, Sandrine Barbaux, P. De Mazancourt, Frederic Sergent, Mohamed Benharouga, Daniel Vaiman, P. Rozenberg, Padma Murthi, Biologie du Cancer et de l'Infection (BCI ), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Department of Perinatal Medicine, Pregnancy Research Centre, The Royal Women's Hospital, Department of Obstetrics and Gynaecology [Melbourne], Melbourne Medical School [Melbourne], Faculty of Medicine, Dentistry and Health Sciences [Melbourne], University of Melbourne-University of Melbourne-Faculty of Medicine, Dentistry and Health Sciences [Melbourne], University of Melbourne-University of Melbourne, Département de Gynécologie, Obstétrique et Médecine de la Reproduction, CHU Grenoble, Unité de pathologie cellulaire et génétique (UPCG), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Institut Cochin (IC UM3 (UMR 8104 / U1016)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Chimie et Biologie des Métaux (LCBM - UMR 5249), Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Biologie du Cancer et de l'Infection ( BCI - UMR S1036 ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Grenoble Alpes ( UGA ) -Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ), Department of Obstetrics and Gynaecology, University of Melbourne, Unité de pathologie cellulaire et génétique ( UPCG ), Université de Versailles Saint-Quentin-en-Yvelines ( UVSQ ), Institut Cochin ( UM3 (UMR 8104 / U1016) ), Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Laboratoire de Chimie et Biologie des Métaux ( LCBM - UMR 5249 ), Université Joseph Fourier - Grenoble 1 ( UJF ) -Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ) -Centre National de la Recherche Scientifique ( CNRS ) -Université Grenoble Alpes ( UGA ), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes (UGA)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), and Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG)
- Subjects
Placental growth factor ,HUMAN TROPHOBLAST ,Placenta ,Giant Cells ,Receptors, G-Protein-Coupled ,Human chorionic gonadotropin ,UMBILICAL ARTERY ,0302 clinical medicine ,Pregnancy ,MOLECULAR CHARACTERIZATION ,Receptor ,[ SDV.MHEP.GEO ] Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics ,Cells, Cultured ,IN-VITRO DIFFERENTIATION ,0303 health sciences ,VILLOUS CYTOTROPHOBLAST DIFFERENTIATION ,Fetal Growth Retardation ,030219 obstetrics & reproductive medicine ,FGR ,Prokineticin ,Cell Hypoxia ,Recombinant Proteins ,Trophoblasts ,Up-Regulation ,3. Good health ,HOMEOBOX GENE HLX1 ,[ SDV.BDLR ] Life Sciences [q-bio]/Reproductive Biology ,medicine.anatomical_structure ,Molecular Medicine ,Female ,medicine.medical_specialty ,Receptors, Peptide ,[SDV.BC]Life Sciences [q-bio]/Cellular Biology ,Biology ,[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics ,CELL-PROLIFERATION ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,HUMAN CHORIONIC-GONADOTROPIN ,Internal medicine ,medicine ,Humans ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,RNA, Messenger ,EG-VEGF ,[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Molecular Biology ,Cell Proliferation ,030304 developmental biology ,Homeodomain Proteins ,Pharmacology ,[ SDV.BC ] Life Sciences [q-bio]/Cellular Biology ,INTRAUTERINE GROWTH ,Trophoblast ,[SDV.BDLR]Life Sciences [q-bio]/Reproductive Biology ,Cell Biology ,Prokineticin receptor 1 ,medicine.disease ,ENDOTHELIAL-CELLS ,Placentation ,Pregnancy Trimester, First ,Endocrinology ,Vascular Endothelial Growth Factor, Endocrine-Gland-Derived ,Angiogenesis ,Transcription Factors - Abstract
International audience; Identifiable causes of fetal growth restriction (FGR) account for 30 % of cases, but the remainders are idiopathic and are frequently associated with placental dysfunction. We have shown that the angiogenic factor endocrine gland-derived VEGF (EG-VEGF) and its receptors, prokineticin receptor 1 (PROKR1) and 2, (1) are abundantly expressed in human placenta, (2) are up-regulated by hypoxia, (3) control trophoblast invasion, and that EG-VEGF circulating levels are the highest during the first trimester of pregnancy, the period of important placental growth. These findings suggest that EG-VEGF/PROKR1 and 2 might be involved in normal and FGR placental development. To test this hypothesis, we used placental explants, primary trophoblast cultures, and placental and serum samples collected from FGR and age-matched control women. Our results show that (1) EG-VEGF increases trophoblast proliferation ([3H]-thymidine incorporation and Ki67-staining) via the homeobox-gene, HLX (2) the proliferative effect involves PROKR1 but not PROKR2, (3) EG-VEGF does not affect syncytium formation (measurement of syncytin 1 and 2 and β hCG production) (4) EG-VEGF increases the vascularization of the placental villi and insures their survival, (5) EG-VEGF, PROKR1, and PROKR2 mRNA and protein levels are significantly elevated in FGR placentas, and (6) EG-VEGF circulating levels are significantly higher in FGR patients. Altogether, our results identify EG-VEGF as a new placental growth factor acting during the first trimester of pregnancy, established its mechanism of action, and provide evidence for its deregulation in FGR. We propose that EG-VEGF/PROKR1 and 2 increases occur in FGR as a compensatory mechanism to insure proper pregnancy progress.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.